Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Lung Neoplasms"
topic_facet:"Carcinoma, Squamous Cell"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Squamous+Cell%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Squamous+Cell%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Squamous+Cell%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (78)
1
Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS : A Phase Ib/II Multicenter Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer : National Lung Matrix Trial: Multi-drug, Genetic Marker-directed, Non-comparative, Multi-centre, Multi-arm Phase II Trial in Non-small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial : Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors : A Phase 2, Open-label, Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer : A Phase IB and Randomized Open-Label Phase II Study of Berzosertib (M6620, VX-970) in Combination With Carboplatin/Gemcitabine/Pembrolizumab in Patients With Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer of Squamous Cell Histology
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors : A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND EXPANSION STUDY OF PF-07265028 AS A SINGLE AGENT AND IN COMBINATION WITH SASANLIMAB EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND ANTI-TUMOR ACTIVITY OF PF-07265028 IN PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer : Phase II Randomized Clinical Trials Comparing Immunotherapy Plus Stereotactic Ablative Radiotherapy (I-SABR) Versus SABR Alone for Stage I, Selected Stage IIa, or Isolated Lung Parenchymal Recurrent Non-Small Cell Lung Cancer: I-SABR
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer : A Phase 1/2, Multicenter, Open Label, Dose Escalation & Dose Expansion Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, Monotherapy or in Combination in Patients With Unresectable Locally Advanced or Metastatic Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors : A Phase II, Single-Arm Open-Label Study of the Combination of Atezolizumab and Bevacizumab in Rare Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy : A Phase 2 Study of MLN4924 (Pevonedistat) in Combination With Carboplatin and Paclitaxel in Advanced NSCLC Previously Treated With Immunotherapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
Nächster »
[8]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Lung Neoplasms
Filter aufheben
Thema: Carcinoma, Squamous Cell
Medienart
78
Aufsätze
78
E-Artikel
78
E-Ressourcen
Zeitschriftentitel
78
ClinicalTrials.gov
Thema
78
610
Carcinoma, Squamous Cell
Lung Neoplasms
71
Study Type: Interventional
62
Carcinoma
50
Carcinoma, Non-Small-Cell Lung
39
Squamous Cell Carcinoma of Head and Neck
33
Phase: Phase 1
19
Recruitment Status: Active, not recruiting
18
Melanoma
18
Recruitment Status: Recruiting
18
Small Cell Lung Carcinoma
16
Phase: Phase 2
15
Recruitment Status: Completed
15
Recruitment Status: Terminated
13
Adenocarcinoma
13
Carcinoma, Renal Cell
13
Head and Neck Neoplasms
12
Stomach Neoplasms
11
Carcinoma, Merkel Cell
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
60
2020-
18
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
78
Englisch
Haven't found what you're looking for?
Wird geladen...